Synthetic gene regulation circuits for control of cell expansion

Tissue Engineering - Part A

Volumn 16, Issue 2, 2010, Pages 441-452

  May, Tobias ^a   Butueva, Milada ^a   Bantner, Sara ^a   Markusic, David ^b   Seppen, Jurgen ^b   MacLeod, Roderick A F ^c   Weich, Herbert ^a   Hauser, Hansjörg ^a   Wirth, Dagmar ^a  

^a HELMHOLTZ CENTRE FOR INFECTION RESEARCH   (Germany)

^b ACADEMIC MEDICAL CENTER   (Netherlands)

^c Department of Cytogenetics DSMZ Deutsche Sammlung für Mikroorganismen und Zellkulturen ^*  (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CELL CULTURE; CELL PROLIFERATION; ENDOTHELIAL CELLS; FEEDBACK; GENE EXPRESSION;

CELL EXPANSION; CELL LINES; CELL TYPES; DIFFERENTIATED CELLS; FLEXIBLE CELL; HUMAN CELLS; HUMAN ENDOTHELIAL CELLS; IN-CELL; IN-VITRO; KEY FEATURE; LENTIVIRAL VECTOR; POSITIVE FEEDBACK LOOP; PRIMARY CELLS; RELIABLE CONTROL; SYNTHETIC GENES;

CLONE CELLS;

LENTIVIRUS; MURINAE;

BIOLOGICAL MARKER;

ANIMAL; ANIMAL EMBRYO; ARTICLE; CELL LINE; CELL PROLIFERATION; CYTOLOGY; ENDOTHELIUM CELL; FIBROBLAST; GENE EXPRESSION REGULATION; GENE REGULATORY NETWORK; GENETIC TRANSDUCTION; GENETICS; HUMAN; LENTIVIRINAE; METABOLISM; MOUSE; UMBILICAL VEIN;

ANIMALS; BIOLOGICAL MARKERS; CELL LINE, TRANSFORMED; CELL PROLIFERATION; EMBRYO, MAMMALIAN; ENDOTHELIAL CELLS; FIBROBLASTS; GENE EXPRESSION REGULATION; GENE REGULATORY NETWORKS; HUMANS; LENTIVIRUS; MICE; TRANSDUCTION, GENETIC; UMBILICAL VEINS;

EID: 77049100733     PISSN: 19373341     EISSN: 1937335X     Source Type: Journal    
DOI: 10.1089/ten.tea.2009.0184     Document Type: Conference Paper

References (35)

1. Bodnar, A.G., Ouellette, M., Frolkis, M., Holt, S.E., Chiu, C.P., Morin, G.B., Harley, C.B., Shay, J.W., Lichtsteiner, S., and Wright, W.E. Extension of life-span by introduction of telomerase into normal human cells. Science 279, 349, 1998.
2. Thomas, M., Suwa, T., Yang, L., Zhao, L., Hawks, C.L., and Hornsby, P.J. Cooperation of hTERT, SV40 T antigen and oncogenic Ras in tumorigenesis: a cell transplantation model using bovine adrenocortical cells. Neoplasia 4, 493, 2002.
3. Yang, J., Nagavarapu, U., Relloma, K., Sjaastad, M.D., Moss, W.C., Passaniti, A., and Herron, G.S. Telomerized human microvasculature is functional in vivo. Nat Biotechnol 19, 219, 2001.
4. Simonsen, J.L., Rosada, C., Serakinci, N., Justesen, J., Sten-derup, K., Rattan, S.I., Jensen, T.G., and Kassem, M. Telo-merase expression extends the proliferative life-span and maintains the osteogenic potential of human bone marrow stromal cells. Nat Biotechnol 20, 592, 2002.
5. Milyavsky, M., Shats, I., Erez, N., Tang, X., Senderovich, S., Meerson, A., Tabach, Y., Goldfinger, N., Ginsberg, D., Harris, C.C., and Rotter, V. Prolonged culture of telomerase-immortalized human fibroblasts leads to a premalignant phenotype. Cancer Res 63, 7147, 2003.
6. Noguchi, H., Kobayashi, N., Westerman, K.A., Sakaguchi, M., Okitsu, T., Totsugawa, T., Watanabe, T., Matsumura, T., Fujiwara, T., Ueda, T., Miyazaki, M., Tanaka, N., and Leboulch, P. Controlled expansion of human endothelial cell populations by Cre-loxP-based reversible immortalization. Hum Gene Ther 13, 321, 2002.
7. Narushima, M., Kobayashi, N., Okitsu, T., Tanaka, Y., Li, S.A., Chen, Y., Miki, A., Tanaka, K., Nakaji, S., Takei, K., Gutierrez, A.S., Rivas-Carrillo, J.D., Navarro-Alvarez, N., Jun, H.S., Westerman, K.A., Noguchi, H., Lakey, J.R., Leboulch, P., Tanaka, N., and Yoon, J.W. A human beta-cell line for transplantation therapy to control type 1 diabetes. Nat Biotechnol 23, 1274, 2005.
8. Westerman, K.A., and Leboulch, P. Reversible immortalization of mammalian cells mediated by retroviral transfer and site-specific recombination. Proc Natl Acad Sci USA 93, 8971, 1996.
9. Cai, Z., Liang, T.J., and Luo, G. Effects of mutations of the initiation nucleotides on hepatitis C virus RNA replication in the cell. J Virol 78, 3633, 2004.
10. Rybkin, I.I., Markham, D.W., Yan, Z., Bassel-Duby, R., Williams, R.S., and Olson, E.N. Conditional expression of SV40 T-antigen in mouse cardiomyocytes facilitates an in-ducible switch from proliferation to differentiation. J Biol Chem 278, 15927, 2003.
11. May, T., Hauser, H., and Wirth, D. Transcriptional control of SV40 T-antigen expression allows a complete reversion of immortalization. Nucleic Acids Res 32, 5529, 2004.
12. Dong, Q.G., Bernasconi, S., Lostaglio, S., De Calmanovici, R.W., Martin-Padura, I., Breviario, F., Garlanda, C., Ram-poni, S., Mantovani, A., and Vecchi, A. A general strategy for isolation of endothelial cells from murine tissues. Characterization of two endothelial cell lines from the murine lung and subcutaneous sponge implants. Arterioscler Thromb Vasc Biol 17, 1599, 1997.
13. May, T., Mueller, P.P., Weich, H., Froese, N., Deutsch, U., Wirth, D., Kroger, A., and Hauser, H. Establishment of murine cell lines by constitutive and conditional immortalization. J Biotechnol 120, 99, 2005.
14. Markusic, D., Oude-Elferink, R., Das, A.T., Berkhout, B., and Seppen, J. Comparison of single regulated lentiviral vectors with rtTA expression driven by an autoregulatory loop or a constitutive promoter. Nucleic Acids Res 33, e63, 2005.
15. Urlinger, S., Baron, U., Thellmann, M., Hasan, M.T., Bujard, H., and Hillen, W. Exploring the sequence space for tetra-cycline-dependent transcriptional activators: novel mutations yield expanded range and sensitivity. Proc Natl Acad Sci USA 97, 7963, 2000.
16. May, T., Hauser, H., and Wirth, D. In vitro expansion of tissue cellsbyconditionalproliferation.MethodsMolMed140,1,2007.
17. Ponce, M.L. Tube formation: an in vitro matrigel angiogen-esis assay. Methods Mol Biol 467, 183, 2009.
18. Delenda, C. Lentiviral vectors: optimization of packaging, transduction and gene expression. J Gene Med 6 Suppl 1, S125, 2004.
19. Wiznerowicz, M., and Trono, D. Harnessing HIV for therapy, basic research and biotechnology. Trends Biotechnol 23, 42, 2005.
20. Kiyono, T., Foster, S.A., Koop, J.I., McDougall, J.K., Galloway, D.A., and Klingelhutz, A.J. Both Rb=p16INK4a inacti-vation and telomerase activity are required to immortalize human epithelial cells. Nature 396, 84, 1998.
21. Hahn, W.C., Counter, C.M., Lundberg, A.S., Beijersbergen, R.L., Brooks, M.W., and Weinberg, R.A. Creation of human tumour cells with defined genetic elements. Nature 400, 464, 1999.
22. Hahn, W.C., and Weinberg, R.A. Rules for making human tumor cells. N Engl J Med 347, 1593, 2002.
23. Rangarajan, A., Hong, S.J., Gifford, A., and Weinberg, R.A. Species-and cell type-specific requirements for cellular transformation. Cancer Cell 6, 171, 2004.
24. Toouli, C.D., Huschtscha, L.I., Neumann, A.A., Noble, J.R., Colgin, L.M., Hukku, B., and Reddel, R.R. Comparison of human mammary epithelial cells immortalized by simian virus 40 T-antigen or by the telomerase catalytic subunit. Oncogene 21, 128, 2002.
25. Antonchuk, J., Sauvageau, G., and Humphries, R.K. HOXB4-induced expansion of adult hematopoietic stem cells ex vivo. Cell 109, 39, 2002.
26. Varnum-Finney, B., Xu, L., Brashem-Stein, C., Nourigat, C., Flowers, D., Bakkour, S., Pear, W.S., and Bernstein, I.D. Pluripotent, cytokine-dependent, hematopoietic stem cells are immortalized by constitutive Notch1 signaling. Nat Med 6, 1278, 2000.
27. Beard, B.C., Dickerson, D., Beebe, K., Gooch, C., Fletcher, J., Okbinoglu, T., Miller, D.G., Jacobs, M.A., Kaul, R., Kiem, H.P., and Trobridge, G.D. Comparison of HIV-derived len-tiviral and MLV-based gammaretroviral vector integration sites in primate repopulating cells. Mol Ther 15, 1356, 2007.
28. Wilson, C.A., and Cichutek, K. The US and EU regulatory perspectives on the clinical use of hematopoietic stem= progenitor cells genetically modified ex vivo by retroviral vectors. Methods Mol Biol 506, 477, 2009.
29. West, A.G., and Fraser, P. Remote control of gene transcription. Hum Mol Genet 14 Spec No 1, R101, 2005.
30. Gaszner, M., and Felsenfeld, G. Insulators: exploiting tran-scriptional and epigenetic mechanisms. Nat Rev Genet 7, 703, 2006.
31. Wirth, D., Gama-Norton, L., Riemer, P., Sandhu, U., Schucht, R., and Hauser, H. Road to precision: recombinase-based targeting technologies for genome engineering. Curr Opin Biotechnol 18, 411, 2007.
32. May, T., Hauser, H., and Wirth, D. Current status of transcriptional regulation systems. Cytotechnology 50, 109, 2006.
33. May, T., Eccleston, L., Herrmann, S., Hauser, H., Goncalves, J., and Wirth, D. Bimodal and hysteretic expression in mammalian cells from a synthetic gene circuit. PLoS ONE 3, e2372, 2008.
34. Gossen, M., and Bujard, H. Tight control of gene expression in mammalian cells by tetracycline-responsive promoters. Proc Natl Acad Sci USA 89, 5547, 1992.
35. Baron, U., Freundlieb, S., Gossen, M., and Bujard, H. Co-regulation of two gene activities by tetracycline via a bidirectional promoter. Nucleic Acids Res 23, 3605, 1995.